British company Advanced Medical Solutions Group plc, a surgical and advanced wound care specialist company, announced on Thursday that it has acquired Haifa-based Sealantis Limited , a developer of an alginate-based tissue adhesive technology platform, for $US 25m (approximately £19m) in cash with royalties due until December 2027 on sales of any of its products that are currently in development.
AMS said it intends to retain Sealantis’ team of 12 research and development staff, who will become a key part of AMS’s surgical R&D capability.